The kinetics of metalloproteinase-9: The significance of the light-dark cycle in metalloproteinase-9 in acute coronary syndrome

Revista Espanola de Cardiologia

Volumn 61, Issue 3, 2008, Pages 327-

  Domínguez Rodríguez, Alberto ^a   Kaski, Juan C ^b   Abreu González, Pedro ^c   García González, Martín J ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; MELATONIN; METALLOPROTEINASE; METALLOPROTEINASE 9; GELATINASE B;

ACUTE CORONARY SYNDROME; BLOOD LEVEL; CIRCADIAN RHYTHM; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; HUMAN; HYPERTENSION; LETTER; LIGHT DARK CYCLE; NEUROENDOCRINE SYSTEM; RISK FACTOR; SMOKING; ENZYMOLOGY; METABOLISM; NOTE; PATHOPHYSIOLOGY;

ACUTE CORONARY SYNDROME; CIRCADIAN RHYTHM; HUMANS; MATRIX METALLOPROTEINASE 9;

EID: 44449095141     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13116663     Document Type: Letter

References (10)

1. Rodríguez JA, Orbe J, Páramo JA. Metaloproteasas, remodelado vascular y síndromes aterotrombóticos. Rev Esp Cardiol. 2007;60:959-67.
2. Tardif JC, Heinonen T, Orloff D, Libby P. Vascular biomarkers and surrogates in cardiovascular disease. Circulation. 2006;113:2936-42.
3. Jones CB, Sane DC, Herrington DM. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Res. 2003;59:812-23.
4. Ferroni P, Basili S, Martini F, Cardarello CM, Ceci F, di Franco M, et al. Serum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation. J Invest Med. 2003;51:295-300.
5. Domínguez Rodríguez A, García González MJ, Abreu González P, Ferrer J, Kaski JC. Relation of nocturnal melatonin levels to C-reactive protein concentration in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2006;97:10-2.
6. Domínguez Rodríguez A, Abreu González P, García González MJ, Ferrer J, de la Rosa A, Vargas M, et al. Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine. 2004;26:89-93.
7. Domínguez Rodríguez A, Abreu González P, García MJ, de la Rosa A, Vargas M, Marrero F. Ritmo luz/oscuridad de las citocinas proinflamatorias en el infarto agudo de miocardio. Rev Esp Cardiol. 2003;56:555-60.
8. Tayebjee MH, Lip GY, Blann AD, MacFadyen RJ. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. Thromb Res. 2005;115:205-10.
9. Dominguez Rodriguez A, Abreu Gonzalez P, Garcia Gonzalez MJ, Reiter RJ. Relation of nocturnal melatonin levels to serum matrix metalloproteinase-9 concentrations in patients with myocardial infarction. Thromb Res. 2007;120:361-6.
10. Kaski JC, Fernández Berges D. Proteína C reactiva en el servicio de urgencias: ¿ha encontrado una aplicación clínica? Rev Esp Cardiol. 2007;60:797-800.